Zevra Therapeutics to Participate in the Citizens Life Science Conference
Zevra Therapeutics (ZVRA), a commercial-stage rare disease therapeutics company, has announced its participation in the upcoming Citizens Life Science Conference in New York. The company's executive leadership team will engage in a fireside chat on Wednesday, May 7, 2025, at 11:30 a.m. ET. Management will also be available for one-on-one meetings with registered conference attendees. Investors can access the live webcast through the "Events & Presentations" section on Zevra's investor relations website at investors.zevra.com.
Zevra Therapeutics (ZVRA), un'azienda specializzata in terapie per malattie rare in fase commerciale, ha annunciato la sua partecipazione alla prossima Citizens Life Science Conference a New York. Il team di leadership esecutiva dell'azienda parteciperà a una conversazione informale il mercoledì 7 maggio 2025, alle 11:30 ET. La direzione sarà inoltre disponibile per incontri individuali con i partecipanti registrati alla conferenza. Gli investitori potranno seguire la diretta streaming tramite la sezione "Events & Presentations" sul sito di relazioni con gli investitori di Zevra all'indirizzo investors.zevra.com.
Zevra Therapeutics (ZVRA), una empresa en etapa comercial dedicada a terapias para enfermedades raras, ha anunciado su participación en la próxima Citizens Life Science Conference en Nueva York. El equipo ejecutivo de la compañía participará en una charla informal el miércoles 7 de mayo de 2025 a las 11:30 a.m. ET. La gerencia también estará disponible para reuniones individuales con los asistentes registrados a la conferencia. Los inversores podrán acceder a la transmisión en vivo a través de la sección "Events & Presentations" en el sitio web de relaciones con inversores de Zevra en investors.zevra.com.
Zevra Therapeutics (ZVRA)는 상업 단계 희귀 질환 치료제 회사로서 뉴욕에서 열리는 Citizens Life Science Conference에 참여한다고 발표했습니다. 회사의 경영진은 2025년 5월 7일 수요일 오전 11시 30분(동부 시간)에 진행되는 파이어사이드 채팅에 참여할 예정입니다. 경영진은 등록된 컨퍼런스 참석자와의 일대일 미팅도 진행할 예정입니다. 투자자들은 Zevra 투자자 관계 웹사이트인 investors.zevra.com의 "Events & Presentations" 섹션을 통해 라이브 웹캐스트를 시청할 수 있습니다.
Zevra Therapeutics (ZVRA), une entreprise en phase commerciale spécialisée dans les traitements des maladies rares, a annoncé sa participation à la prochaine Citizens Life Science Conference à New York. L'équipe de direction exécutive de la société participera à une discussion informelle le mercredi 7 mai 2025 à 11h30 ET. La direction sera également disponible pour des réunions individuelles avec les participants enregistrés à la conférence. Les investisseurs pourront accéder à la diffusion en direct via la section "Events & Presentations" sur le site des relations investisseurs de Zevra à l'adresse investors.zevra.com.
Zevra Therapeutics (ZVRA), ein Unternehmen in der kommerziellen Phase für Therapien seltener Krankheiten, hat seine Teilnahme an der bevorstehenden Citizens Life Science Conference in New York angekündigt. Das Führungsteam des Unternehmens wird am Mittwoch, den 7. Mai 2025, um 11:30 Uhr ET an einem Kamin-Gespräch teilnehmen. Das Management steht außerdem für Einzelgespräche mit registrierten Konferenzteilnehmern zur Verfügung. Investoren können den Live-Webcast über den Bereich "Events & Presentations" auf der Investor-Relations-Website von Zevra unter investors.zevra.com verfolgen.
- None.
- None.
CELEBRATION, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra’s executive leadership team will participate in a fireside chat at the Citizens Life Science Conference in New York, NY, on Wednesday, May 7, 2025, at 11:30 a.m. ET.
Additionally, management will be available for one-on-one meetings with registered attendees at each conference. The live webcasts will be accessible via “Events & Presentations” on the Investor Relations section of Zevra’s website at investors.zevra.com.
About Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc. is a commercial-stage company combining science, data, and patient need to create transformational therapies for rare diseases with limited or no treatment options. Our mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, the Company is overcoming complex drug development challenges to make new therapies available to the rare disease community.
For more information, please visit www.zevra.com or follow us on X and LinkedIn.
Caution Concerning Forward-Looking Statements
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding upcoming events or Zevra’s participation at such events. Forward-looking statements are based on information currently available to Zevra and its current plans or expectations. They are subject to several known and unknown uncertainties, risks, and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. These and other important factors are described in detail in the "Risk Factors" section of Zevra’s Annual Report on Form 10-K for the year ended Dec. 31, 2024, and Zevra’s other filings with the Securities and Exchange Commission. While we may elect to update such forward-looking statements at some point in the future, except as required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. Although we believe the expectations reflected in such forward-looking statements are reasonable, we cannot assure that such expectations will prove correct. These forward-looking statements should not be relied upon as representing our views as of any date after the date of this press release.
Zevra Contact
Nichol Ochsner
+1 (732) 754-2545
nochsner@zevra.com
FAQ
When is Zevra Therapeutics (ZVRA) presenting at the Citizens Life Science Conference?
How can investors watch Zevra Therapeutics' (ZVRA) presentation at the Citizens Life Science Conference?
Will Zevra Therapeutics (ZVRA) management be available for meetings at the Citizens Life Science Conference?
What type of company is Zevra Therapeutics (ZVRA)?
